Jane Street’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.6K | Buy |
+114,354
| New | +$68.6K | ﹤0.01% | 5050 |
|
|
2024
Q3 | – | Sell |
-37,476
| Closed | -$112K | – | 6449 |
|
|
2024
Q2 | $112K | Sell |
37,476
-137,753
| -79% | -$413K | ﹤0.01% | 5588 |
|
|
2024
Q1 | $815K | Buy |
175,229
+163,094
| +1,344% | +$758K | ﹤0.01% | 3450 |
|
|
2023
Q4 | $50.2K | Buy |
+12,135
| New | +$50.2K | ﹤0.01% | 5400 |
|
|
2023
Q3 | – | Sell |
-12,118
| Closed | -$29.8K | – | 5627 |
|
|
2023
Q2 | $29.8K | Buy |
+12,118
| New | +$29.8K | ﹤0.01% | 5021 |
|
|
2023
Q1 | – | Sell |
-118,583
| Closed | -$414K | – | 6108 |
|
|
2022
Q4 | $414K | Buy |
+118,583
| New | +$414K | ﹤0.01% | 3615 |
|
|
2022
Q3 | – | Sell |
-12,348
| Closed | -$234K | – | 6247 |
|
|
2022
Q2 | $234K | Sell |
12,348
-43,395
| -78% | -$822K | ﹤0.01% | 4319 |
|
|
2022
Q1 | $1.51M | Buy |
+55,743
| New | +$1.51M | ﹤0.01% | 2451 |
|
|
2021
Q3 | – | Sell |
-18,919
| Closed | -$606K | – | 5785 |
|
|
2021
Q2 | $606K | Buy |
+18,919
| New | +$606K | ﹤0.01% | 3207 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5317 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 4319 |
|
|
2020
Q3 | – | Sell |
-18,698
| Closed | -$836K | – | 4326 |
|
|
2020
Q2 | $836K | Buy |
18,698
+10,762
| +136% | +$481K | ﹤0.01% | 2096 |
|
|
2020
Q1 | $271K | Buy |
+7,936
| New | +$271K | ﹤0.01% | 2655 |
|